Clinical Value of 18 F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Clinical Value of 18 F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer

Published:2018-08 Issue:8 Volume:30 Page:507-514
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Hynninen J.^ORCID,Laasik M.,Vallius T.,Kemppainen J.,Grönroos S.,Virtanen J.,Casado J.,Hautaniemi S.,Grenman S.,Seppänen M.,Auranen A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference33 articles.

1. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

2. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline;Wright;Gynecol Oncol,2016

3. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J Clin Oncol,2002

4. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists’ Group;Aabo;Br J Cancer,1998

5. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Ledermann;Ann Oncol,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET/Computed Tomography Transformation of Oncology;PET Clinics;2024-04

2. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer;Nuclear Oncology;2022

3. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer;Nuclear Oncology;2022

4. Diagnostic Applications of Nuclear Medicine: Ovarian Cancer;Nuclear Oncology;2022

5. EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA);European Journal of Nuclear Medicine and Molecular Imaging;2021-07-03